UY26787A1 - Derivados de 3-azabiciclo (3.1.0.) hexano útiles en terapia - Google Patents

Derivados de 3-azabiciclo (3.1.0.) hexano útiles en terapia

Info

Publication number
UY26787A1
UY26787A1 UY26787A UY26787A UY26787A1 UY 26787 A1 UY26787 A1 UY 26787A1 UY 26787 A UY26787 A UY 26787A UY 26787 A UY26787 A UY 26787A UY 26787 A1 UY26787 A1 UY 26787A1
Authority
UY
Uruguay
Prior art keywords
useful
derivatives
azabiciclo
hexano
therapy
Prior art date
Application number
UY26787A
Other languages
English (en)
Spanish (es)
Inventor
Ashley Edward Fenwick
Bernard Joseph Banks
Douglas James Critcher
David Morris Gethin
Stephen Paul Gibson
Mr Graham Lunn
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of UY26787A1 publication Critical patent/UY26787A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
UY26787A 2000-06-23 2001-06-21 Derivados de 3-azabiciclo (3.1.0.) hexano útiles en terapia UY26787A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0015562.2A GB0015562D0 (en) 2000-06-23 2000-06-23 Heterocycles
PCT/IB2001/001035 WO2001098267A1 (en) 2000-06-23 2001-06-07 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity

Publications (1)

Publication Number Publication Date
UY26787A1 true UY26787A1 (es) 2002-01-31

Family

ID=9894368

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26787A UY26787A1 (es) 2000-06-23 2001-06-21 Derivados de 3-azabiciclo (3.1.0.) hexano útiles en terapia

Country Status (34)

Country Link
EP (1) EP1292574A1 (ru)
JP (1) JP2004512263A (ru)
KR (1) KR20040002386A (ru)
CN (1) CN1639121A (ru)
AP (1) AP2002002698A0 (ru)
AR (1) AR028969A1 (ru)
AU (1) AU781837B2 (ru)
BG (1) BG107329A (ru)
BR (1) BR0111867A (ru)
CA (1) CA2412188A1 (ru)
CZ (1) CZ20023967A3 (ru)
DO (1) DOP2001000187A (ru)
DZ (1) DZ3368A1 (ru)
EA (1) EA005117B1 (ru)
GB (1) GB0015562D0 (ru)
HR (1) HRP20020998A2 (ru)
HU (1) HUP0301228A3 (ru)
IL (1) IL153427A0 (ru)
IS (1) IS6637A (ru)
MA (1) MA26915A1 (ru)
MX (1) MXPA02012878A (ru)
NO (1) NO20026168L (ru)
NZ (1) NZ523141A (ru)
OA (1) OA12293A (ru)
PA (1) PA8519401A1 (ru)
PE (1) PE20020253A1 (ru)
PL (1) PL365956A1 (ru)
SK (1) SK17172002A3 (ru)
TN (1) TNSN01094A1 (ru)
UA (1) UA73176C2 (ru)
UY (1) UY26787A1 (ru)
WO (1) WO2001098267A1 (ru)
YU (1) YU91802A (ru)
ZA (1) ZA200210278B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0213464A (pt) 2001-10-22 2004-11-09 Pfizer Prod Inc Derivados de 3-azabiciclo[3.1.0]hexano como antagonistas receptores de opióide
EP2074997A1 (en) * 2002-05-17 2009-07-01 Tioga Pharmaceuticals, Inc. Use of Asimadoline for the treatment of digestive disorders
DE10259245A1 (de) 2002-12-17 2004-07-01 Merck Patent Gmbh Derivate des Asimadolins mit kovalent gebundenen Säuren
DK1745040T3 (da) 2004-02-23 2010-04-12 Glaxo Group Ltd Som modulatorer af dopamin-D3-receptorer anvendelige azabicyclo(3.1.0)hexanederivater
GB0507680D0 (en) * 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
JP5068747B2 (ja) * 2005-06-14 2012-11-07 グラクソ グループ リミテッド ドーパミンd3受容体のモジュレーターとしてのアザビシクロ[3.1.0]ヘキサン誘導体
WO2007113258A1 (en) * 2006-04-03 2007-10-11 Glaxo Group Limited Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors
EP2561870A1 (en) 2007-03-30 2013-02-27 Tioga Pharmaceuticals, Inc. Kappa-Opiate Agonists For The Treatment Of Diarrhea-Predominant and Alternating Irritable Bowel Syndrome
TWI423801B (zh) * 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之8-氮雜雙環〔3.2.1〕辛基-2-羥基苯甲醯胺化合物
AU2011263417B2 (en) 2010-06-11 2014-03-27 Rhodes Technologies Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof
WO2012042539A2 (en) 2010-09-28 2012-04-05 Panacea Biotec Ltd Novel bicyclic compounds
KR102305244B1 (ko) * 2013-11-20 2021-09-27 우베 고산 가부시키가이샤 신규 3-아자비사이클로[3.1.0]헥산 유도체 및 그 의약 용도
JP6087035B1 (ja) 2015-05-20 2017-03-01 株式会社三和化学研究所 新規3−アザビシクロ[3.1.0]ヘキサン誘導体の塩の結晶及びその医薬用途
BR112019016827A2 (pt) * 2017-02-17 2020-04-07 Trevena Inc compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 5 membros, métodos de uso e produção dos mesmos
CA3052479A1 (en) 2017-02-17 2018-08-23 Trevena, Inc. 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
AU2018229062A1 (en) 2017-03-02 2019-09-26 Ube Industries, Ltd. Therapeutic agent for alcohol use disorders
CN108250088B (zh) * 2018-01-04 2020-10-30 四川之江高新材料股份有限公司 N,n,n′-三甲基-n′-羟乙基双氨基乙基醚的制备方法
CN115825305B (zh) * 2022-10-21 2024-09-20 昆明理工大学 一种分子印迹固相微萃取纤维及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065230A (en) * 1959-03-16 1962-11-20 Burroughs Wellcome Co Azabicyclohexanes and method of preparing them
ES2058265T3 (es) * 1987-04-16 1994-11-01 Lilly Co Eli Piperidinas antagonistas de opiaceos.
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
TWI244481B (en) * 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
PE20001420A1 (es) * 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5

Also Published As

Publication number Publication date
AR028969A1 (es) 2003-05-28
BG107329A (en) 2003-07-31
HUP0301228A2 (hu) 2003-08-28
HUP0301228A3 (en) 2005-08-29
YU91802A (sh) 2006-05-25
PL365956A1 (en) 2005-01-24
IS6637A (is) 2002-11-28
EA200201269A1 (ru) 2003-06-26
DZ3368A1 (fr) 2001-12-27
PE20020253A1 (es) 2002-04-08
IL153427A0 (en) 2003-07-06
SK17172002A3 (sk) 2004-09-08
AU6259101A (en) 2002-01-02
BR0111867A (pt) 2003-07-01
NO20026168L (no) 2003-02-18
MXPA02012878A (es) 2003-05-14
ZA200210278B (en) 2003-12-19
EA005117B1 (ru) 2004-10-28
AP2002002698A0 (en) 2002-12-31
HRP20020998A2 (en) 2004-02-29
PA8519401A1 (es) 2002-12-30
DOP2001000187A (es) 2002-03-30
WO2001098267A1 (en) 2001-12-27
OA12293A (en) 2004-03-18
NZ523141A (en) 2005-06-24
EP1292574A1 (en) 2003-03-19
CZ20023967A3 (cs) 2004-02-18
GB0015562D0 (en) 2000-08-16
KR20040002386A (ko) 2004-01-07
UA73176C2 (en) 2005-06-15
WO2001098267A8 (en) 2003-02-27
MA26915A1 (fr) 2004-12-20
JP2004512263A (ja) 2004-04-22
CN1639121A (zh) 2005-07-13
TNSN01094A1 (fr) 2005-11-10
CA2412188A1 (en) 2001-12-27
NO20026168D0 (no) 2002-12-20
AU781837B2 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
UY26787A1 (es) Derivados de 3-azabiciclo (3.1.0.) hexano útiles en terapia
MXPA04004370A (es) Derivados policiclicos de guanina inhibidores de fosfodiesterasa v.
MY138478A (en) Benzazepine derivatives for the treatment of neurological disorders
BR0316753A (pt) Método de tratamento para disfunção sexual
GB0329214D0 (en) Novel compounds
ECSP056202A (es) Derivados de imidazol como antagonistas del receptor del glutamato
CA2422698A1 (en) Indoline derivatives and their use as 5-ht2 receptor ligands
WO2006018279A3 (de) Arylsubstituierte polycyclische amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CR9149A (es) Derivados de rapamicina y los usos de los mismos en el tratamiento de trastornos neurologicos
MX2007004794A (es) Tienopiridinas como potenciadores alostericos del receptor muscarinico m4.
CR7510A (es) DERIVADOS DE [1-4] DIAZEPINO[6,7,1-iJ)] QUINOLONA COMO AGENTES ANTIPSICOTICOS Y CONTRA LA OBESIDAD
PT1736157E (pt) Derivados de morfinano como agentes anti-prurido
CR9622A (es) Derivados de pirazolo[3,4-d]azepina como antagonistas de histamina h3
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
PA8527901A1 (es) Derivados de quinazolin como un antagonista del adrenèrgico alfa-1
NZ597866A (en) Therapeutic lactams
BR0308567A (pt) derivados de glicosìdeo e glicosìdeo de ortoéster de apomorfina, análogos, e seus usos
TW200621223A (en) Acyclic 1,3-diamines and uses therefor
WO2007128827A8 (en) 17-oxymacbecin derivatives and their use in the treatment of cancer and/or b-cell malignancies
SV2002000459A (es) Derivados de sulfonamidas ref. x-13840
GB0317491D0 (en) Organic compounds
BR0202768A (pt) Derivados de 1-difenilmetil-pirazol como ligandos de receptores de opiáceos
AR043306A1 (es) N- ureidoalquil-piperidinas como moduladores de la actividad del receptor de quimiocina
UA92330C2 (en) 2-acylaminothiazole derivatives
DOP2004000920A (es) Derivados de imidazol como antagonistas de receptor de glutamato

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20140212